1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
Eisai Co., Ltd.Small moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Esomeprazole National Taiwan University Hospital | Phase 2 | CCC |
Orelabrutinib Fudan University | Phase 2 | CCC |
BISMUTH SUBCITRATE National Taiwan University Hospital | Phase 2 | CCC |
METRONIDAZOLE National Taiwan University Hospital | Phase 2 | CCC |
Tetracycline National Taiwan University Hospital | Phase 2 | CCC |
View all 10 →
Same molecule, other indications
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →